Troikaa Pharma bags Award for Excellence from FGI

Bangalore, May 14, 2010: Troikaa Pharmaceuticals has been conferred with the prestigious Award for Excellence in 'Research in Science and Technology' for the year 2009 by the Federation of Gujarat Industries (FGI). Troikaa won the award for in-house research in developing the world's first painless diclofenac injection - Dynapar AQ. Dr. Montek Singh Ahluwalia, Deputy Chairman, Planning Commission, Government of India, presented the award at a function organized by FGI.

Mr. Ketan Patel, Managing Director, Troikaa Pharmaceuticals, said, "This award recognizes our sustained commitment to develop innovative drug delivery systems for patients. This is the second award conferred on the company for the innovative product Dynapar AQ."

Within two-and-a-half years of launch, Dynapar AQ is the second largest brand of diclofenac injections in the country. The company has been granted the patent for this product in India as well as in 29 other countries and is in the process of procuring patents in 70 other countries.

Diclofenac injections are routinely used for management of acute pain and inflammation. Dynapar AQ injections are the world's only diclofenac injections that can be administered in the arm muscles, especially useful in obese and overweight patients and those with large amount of fat on the buttocks. It is also the first diclofenac available in pre-filled syringes.

FGI presents biennial awards for excellence in economic, societal and scientific areas. This year, FGI has constituted awards for excellence in 13 categories across different fields.